Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.

Jose Tinajero discusses how certain mutations can be indicators of blinatumomab treatment failure in patients with B-cell acute lymphoblastic leukemia.

Mazyar Shadman, MD, MPH, discusses the continued efficacy of zanubrutinib in patients with chronic lymphocytic leukemia.

Al Carter of the National Association of Boards of Pharmacy speaks on recent initiatives to address workforce burnout and stress among pharmacists.

Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans.

The workshop addressed trends, initiatives, and regulations for quality compounding.

Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health.

Harpreet Bhatia, MD, MAS, FACC, discusses emerging new approaches to lipid lowering therapies.

Rachel Chandra, PharmD, MPH, FASHP, shares insight into the VALOR-QI program.